Home |  About AFMR |  Membership |  AFMR Regions |  Awards |  Publications |  Public Policy |  Press Releases |  Career Connections |  Links

2009 Southern Regional Meeting Abstracts


Session: Joint Plenary Poster Session and Reception

X-LINKED AGAMMAGLOBULINEMIA WITH ISOLATED IGM DEFICIENCY
Bell MC1, Perry TT1,2, Scurlock AM1,2, Jones SM1,2. 1University of Arkansas for Medical Sciences, Little Rock, AR and 2Arkansas Children's Hospital, Little Rock, AR.

Case Report: Purpose of Study: Case review of three brothers with X-Linked Agammaglobulinemia (XLA) caused by bruton's tyrosine kinase (BTK) gene mutation with atypical laboratory findings.
Methods Used: A retrospective chart review was used to describe cases of three brothers with recurrent sinopulmonary infections.
Summary of Results: LM presented at age 6.5 years with pneumonia. His history was significant for Kingella kingae osteomyelitis (18 months) and a previous episode of pneumonia (6 years). Immunologic workup revealed low absolute circulating B cells, absent IgM (<10 mg/dL), and normal IgG, IgA, and IgE. Pre and post vaccination titers revealed a normal response to diptheria and tetanus but no response to 14/14 pneumococcal serotypes. LM was started on monthly intravenous immunoglobulin (IvIg) and later switched to subcutaneous immunoglobulin (ScIg) therapy. LM, now 9 years old, has had no infections since starting immunoglobulin therapy.
KM presented at age 2 years after bilateral pressure equalization tubes (PET) placement. His history included chronic rhinorrhea, 1 episode each of pneumonia and bronchiolitis, and recurrent otitis media. KM’s immunologic testing revealed low absolute B cells, no response to pneumococcal vaccine, absent IgM, and normal IgG, IgA, and IgE. KM, now 4 years old, has continued to have recurrent otitis media requiring a second set of PET and antibiotics despite monthly IvIg.
BM presented with recurrent otitis media and gastroenteritis requiring hospitalization at age 16 months. BM had low absolute B cells, absent IgM, and normal IgG, IgA, and IgE. BM was started on IvIg therapy and has done well. Genetic testing for XLA was obtained on the brothers and sequencing revealed a 167T>C mutation in the BTK gene causing an Ile56Thr missense mutation (previously described). A fourth brother has had no clinical recurrent infections and normal BTK gene sequence. Maternal BTK gene profile is pending.
Conclusions: XLA is a rare humoral immunodeficiency due to BTK gene mutations resulting in a paucity of circulating B cells and low-absent serum immunoglobulins. To our knowledge, we are the first to report a family cohort of XLA with an isolated low IgM in the presence of normal IgG, IgA, and IgE.